Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Brazeau N"'
Autor:
McCabe, R, Sheppard, R, Abdelmagid, N, Ahmed, A, Alabdeen, IZ, Brazeau, N, Abd Elhameed, AEA, Bin-Ghouth, AS, Hamlet, A, AbuKoura, R, Barnsley, G, Hay, J, Alhaffar, M, Besson, EK, Saje, SM, Sisay, BG, Gebreyesus, SH, Sikamo, AP, Worku, A, Ahmed, YS, Mariam, DH, Sisay, MM, Checchi, F, Dahab, M, Endris, BS, Ghani, A, Walker, P, Donnelly, C, Watson, O
Not all COVID-19 deaths are officially reported, and particularly in low-income and humanitarian settings, the magnitude of reporting gaps remains sparsely characterized. Alternative data sources, including burial site worker reports, satellite image
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::5a8a5afef98efc1b2bad82d5ca2cda05
http://hdl.handle.net/10044/1/104620
http://hdl.handle.net/10044/1/104620
Autor:
Watson, O, Abdelmagid, N, Ahmed, A, Ahmed Abd Elhameed, AE, Whittaker, C, Brazeau, N, Hamlet, A, Walker, P, Hay, J, Ghani, A, Checchi, F, Dahab, M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64545320eaecfa54b4e43cb9999617c8
http://hdl.handle.net/10044/1/84283
http://hdl.handle.net/10044/1/84283
Autor:
Brazeau, N, Verity, R, Jenks, S, Fu, H, Whittaker, C, Winskill, P, Dorigatti, I, Walker, P, Riley, S, Schnekenberg, RP, Heltgebaum, H, Mellan, T, Mishra, S, Unwin, H, Watson, O, Cucunuba Perez, Z, Baguelin, M, Whittles, L, Bhatt, S, Ghani, A, Ferguson, N, Okell, L
The infection fatality ratio (IFR) is a key statistic for estimating the burden of coronavirus disease 2019 (COVID-19) and has been continuously debated throughout the current pandemic. Previous estimates have relied on data early in the epidemic, or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7660654a9ef87cc316548c5df9686170
http://hdl.handle.net/10044/1/83545
http://hdl.handle.net/10044/1/83545
Autor:
Hogan, A, Winskill, P, Watson, O, Walker, P, Whittaker, C, Baguelin, M, Haw, D, Lochen, A, Gaythorpe, K, Ainslie, K, Bhatt, S, Boonyasiri, A, Boyd, O, Brazeau, N, Cattarino, L, Charles, G, Cooper, L, Coupland, H, Cucunuba Perez, Z, Cuomo-Dannenburg, G, Donnelly, C, Dorigatti, I, Eales, O, Van Elsland, S, Ferreira Do Nascimento, F, Fitzjohn, R, Flaxman, S, Green, W, Hallett, T, Hamlet, A, Hinsley, W, Imai, N, Jauneikaite, E, Jeffrey, B, Knock, E, Laydon, D, Lees, J, Mellan, T, Mishra, S, Nedjati Gilani, G, Nouvellet, P, Ower, A, Parag, K, Ragonnet-Cronin, M, Siveroni, I, Skarp, J, Thompson, H, Unwin, H, Verity, R, Vollmer, M, Volz, E, Walters, C, Wang, H, Wang, Y, Whittles, L, Xi, X, Muhib, F, Smith, P, Hauck, K, Ferguson, N, Ghani, A
Several SARS-CoV-2 vaccine candidates are now in late-stage trials, with efficacy and safety results expected by the end of 2020. Even under optimistic scenarios for manufacture and delivery, the doses available in 2021 are likely to be limited. Here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b138e6de39a30132ccb293722242dc02
http://hdl.handle.net/10044/1/82822
http://hdl.handle.net/10044/1/82822
Autor:
Monod, M, Blenkinsop, A, Xi, X, Herbert, D, Bershan, S, Tietze, S, Bradley, V, Chen, Y, Coupland, H, Filippi, S, Ish-Horowicz, J, McManus, M, Mellan, T, Gandy, A, Hutchinson, M, Unwin, H, Vollmer, M, Weber, S, Zhu, H, Bezancon, A, Ferguson, N, Mishra, S, Flaxman, S, Bhatt, S, Ratmann, O, Ainslie, K, Baguelin, M, Boonyasiri, A, Boyd, O, Cattarino, L, Cooper, L, Cucunuba Perez, Z, Cuomo-Dannenburg, G, Djaafara, A, Dorigatti, I, Van Elsland, S, Fitzjohn, R, Gaythorpe, K, Geidelberg, L, Green, W, Hamlet, A, Jeffrey, B, Knock, E, Laydon, D, Nedjati Gilani, G, Nouvellet, P, Parag, K, Siveroni, I, Thompson, H, Verity, R, Walters, C, Donnelly, C, Okell, L, Bhatia, S, Brazeau, N, Eales, O, Haw, D, Imai, N, Jauneikaite, E, Lees, J, Mousa, A, Olivera Mesa, D, Skarp, J, Whittles, L
Following inial declines, in mid 2020, a resurgence in transmission of novel coronavirus disease (COVID-19) has occurred in the United States and parts of Europe. Despite the wide implementaon of non-pharmaceucal inter-venons, it is s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78719a3a8d3b8e4b6d1ff318b6fc3a21
Autor:
Van Elsland, S, Watson, O, Alhaffar, M, Mehchy, Z, Whittaker, C, Akil, Z, Ainslie, K, Baguelin, M, Bhatt, S, Boonyasiri, A, Boyd, O, Brazeau, N, Cattarino, L, Charles, G, Ciavarella, C, Cooper, L, Coupland, H, Cucunuba Perez, Z, Cuomo-Dannenburg, G, Djaafara, A, Donnelly, C, Dorigatti, I, Eales, O, Nascimento, F, Fitzjohn, R, Flaxman, S, Forna, A, Fu, H, Gaythorpe, K, Green, W, Hamlet, A, Hauck, K, Haw, D, Hayes, S, Hinsley, W, Imai, N, Jeffrey, B, Johnson, R, Jorgensen, D, Knock, E, Laydon, D, Lees, J, Mellan, T, Mishra, S, Nedjati Gilani, G, Nouvellet, P, Okell, L, Olivera Mesa, D, Pons Salort, M, Ragonnet-Cronin, M, Siveroni, I, Stopard, I, Thompson, H, Unwin, H, Verity, R, Vollmer, M, Volz, E, Walters, C, Wang, H, Wang, Y, Whittles, L, Winskill, P, Xi, X, Ferguson, N, Beals, E, Walker, P, Anonymous Authors
The COVID-19 pandemic has resulted in substantial mortality worldwide. However, to date, countries in the Middle East and Africa have reported substantially lower mortality rates than in Europe and the Americas. One hypothesis is that these countries
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19578c179dbb4594931beb37c08e54ad
http://hdl.handle.net/10044/1/82443
http://hdl.handle.net/10044/1/82443
Autor:
Fu, H, Xi, X, Wang, H, Boonyasiri, A, Wang, Y, Hinsley, W, Fraser, K, McCabe, R, Olivera Mesa, D, Skarp, J, Ledda, A, Dewe, T, Dighe, A, Winskill, P, Van Elsland, S, Ainslie, K, Baguelin, M, Bhatt, S, Boyd, O, Brazeau, N, Cattarino, L, Charles, G, Coupland, H, Cucunuba Perez, Z, Cuomo-Dannenburg, G, Donnelly, C, Dorigatti, I, Green, W, Hamlet, A, Hauck, K, Haw, D, Jeffrey, B, Laydon, D, Lees, J, Mellan, T, Mishra, S, Nedjati Gilani, G, Nouvellet, P, Okell, L, Parag, K, Ragonnet-Cronin, M, Riley, S, Schmit, N, Thompson, H, Unwin, H, Verity, R, Vollmer, M, Volz, E, Walker, P, Walters, C, Watson, O, Whittaker, C, Whittles, L, Imai, N, Bhatia, S, Ferguson, N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::725a547588d499a12d4dcdb639116e7e
http://hdl.handle.net/10044/1/80360
http://hdl.handle.net/10044/1/80360
Autor:
Hogan, A, Jewell, B, Sherrard-Smith, E, Watson, O, Whittaker, C, Hamlet, A, Smith, J, Winskill, P, Verity, R, Baguelin, M, Lees, J, Whittles, L, Ainslie, K, Bhatt, S, Boonyasiri, A, Brazeau, N, Cattarino, L, Cooper, L, Coupland, H, Cuomo-Dannenburg, G, Dighe, A, Djaafara, A, Donnelly, C, Eaton, J, Van Elsland, S, Fitzjohn, R, Fu, H, Gaythorpe, K, Green, W, Haw, D, Hayes, S, Hinsley, W, Imai, N, Laydon, D, Mangal, T, Mellan, T, Mishra, S, Parag, K, Thompson, H, Unwin, H, Vollmer, M, Walters, C, Wang, H, Ferguson, N, Okell, L, Churcher, T, Arinaminpathy, N, Ghani, A, Walker, P, Hallett, T
Publikováno v:
e1141
e1132
e1132
Background: COVID-19 has the potential to cause substantial disruptions to health services, including by cases overburdening the health system or response measures limiting usual programmatic activities. We aimed to quantify the extent to which disru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::f9255cd1f99581a83f2da9d2876a419a
http://hdl.handle.net/10044/1/80149
http://hdl.handle.net/10044/1/80149
Autor:
Nouvellet, P, Bhatia, S, Cori, A, Ainslie, K, Baguelin, M, Bhatt, S, Boonyasiri, A, Brazeau, N, Cattarino, L, Cooper, L, Coupland, H, Cucunuba Perez, Z, Cuomo-Dannenburg, G, Dighe, A, Djaafara, A, Dorigatti, I, Eales, O, Van Elsland, S, Nscimento, F, Fitzjohn, R, Gaythorpe, K, Geidelberg, L, Grassly, N, Green, W, Hamlet, A, Hauck, K, Hinsley, W, Imai, N, Jeffrey, B, Knock, E, Laydon, D, Lees, J, Mangal, T, Mellan, T, Nedjati Gilani, G, Parag, K, Pons Salort, M, Ragonnet-Cronin, M, Riley, S, Unwin, H, Verity, R, Vollmer, M, Volz, E, Walker, P, Walters, C, Wang, H, Watson, O, Whittaker, C, Whittles, L, Xi, X, Ferguson, N, Donnelly, C
In response to the COVID-19 pandemic, countries have sought to control transmission of SARS-CoV-2 by restricting population movement through social distancing interventions, reducing the number of contacts. Mobility data represent an important proxy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b56abec7ed39983b303fec89ab04191f
http://hdl.handle.net/10044/1/79643
http://hdl.handle.net/10044/1/79643
Autor:
Jeffrey, B, Walters, C, Ainslie, K, Eales, O, Ciavarella, C, Bhatia, S, Hayes, S, Baguelin, M, Boonyasiri, A, Brazeau, N, Cuomo-Dannenburg, G, Fitzjohn, R, Gaythorpe, K, Green, W, Imai, N, Mellan, T, Mishra, S, Nouvellet, P, Unwin, H, Verity, R, Vollmer, M, Whittaker, C, Ferguson, N, Donnelly, C, Riley, S
Since early March 2020, the COVID-19 epidemic across the United Kingdom has led to a range of social distancing policies, which have resulted in reduced mobility across different regions. Crowd level data on mobile phone usage can be used as a proxy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ace2d4c75e5c41370fea9be267657c33